Professional Documents
Culture Documents
2020
• Berbagai Artikel
Clinical course and risk factors for mortality of adult
inpatients with COVID-19 in Wuhan, China: a retrospective
cohort study
Fei Zhou*, Ting Yu*, Ronghui Du*, Guohui Fan*, Ying Liu*, Zhibo Liu*, Jie Xiang*, Yeming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei,
Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, Bin Cao
Summary
Lancet 2020; 395: 1054–62 Background Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019
Published Online (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and
March 9, 2020 clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed
https://doi.org/10.1016/
clinical course of illness, including viral shedding, have not been well described.
S0140-6736(20)30566-3
See Comment page 1014
Methods In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-
This online publication has been
corrected. The corrected version
confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been
first appeared at thelancet.com discharged or had diedWhyby Do
JanWe
31, Need
2020. Antibody
Demographic,
Tests clinical, treatment,and
for COVID-19 and How
laboratory data, including
to Interpret serial
Test Results
on March 12, 2020 samples for viral RNA detection, were extracted from electronic medical records and compared between survivors
*Contributed equally and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors
Why Do We Need Antibody Tests for COVID-19?
Department of Pulmonary and associated with in-hospital death.viral infections currently relies on two major methodologies: Reverse Transcription
Diagnosing
Critical Care Medicine, Center of
Quantitative Polymerase Chain Reaction (RT-qPCR) and serological immunoassays that detect viral-
Respiratory Medicine, National
Findings 191 patients (135 from
specific Jinyintan
antibodies Hospital
(IgM and IgG)and
or 56 from Wuhan Pulmonary Hospital) were included in this
antigens.
Clinical Research Center for
Respiratory Diseases, Institute study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension
being the most common Although, RT-qPCR
(58 [30%] is a highly
patients), sensitive
followed test for SARS-CoV-2
by diabetes (the virusand
(36 [19%] patients) thatcoronary
causes COVID-19) it has
heart disease
of Respiratory Medicine,
PENDAHULUAN
TRIAS Enviro
nment
EPIDEMIOLOGI
DISEASE
NATURAL HISTORY OF DISEASE
Sudah
bergejala Komplikasi
lanjut
Sembuh
Belum bergejala, sudah ada
perubahan dalam tubuh
35
Why Do We Need Antibody Test for Covid-19 and How to Interpret
Test Results, Diazyme Laboratories, 2020
Figure 1: Variation of the Levels of SARS-CoV-2 RNA and Antigen, IgM and IgG after infection.
Survivors
Fever
Cough
Dyspnoea
ICU admission
Systematic corticosteroid
SARS-CoV-2 RNA positive
Days after illness onset Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 Day 15 Day 16 Day 17 Day 18 Day 19 Day 20 Day 21 Day 22
Non-survivors
Fever
Cough
Dyspnoea
ICU admission
Invasive ventilation
Systematic corticosteroid
SARS-CoV-2 RNA positive
Days after illness onset Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 Day 15 Day 16 Day 17 Day 18 Day 19 Day 20
Figure 1: Clinical courses of major symptoms and outcomes and duration of viral shedding from illness onset in patients hospitalised with COVID-19
Figure shows median duration of symptoms and onset of complications and outcomes. ICU=intensive care unit. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. ARDS=acute respiratory
distress syndrome. COVID-19=coronavirus disease 2019.
increase in differential expression of genes associated pneumonia include older age, pre-existing cardiovascular
with inflammation, whereas expression of type I inter- diseases, and greater severity of pneumonia at presen-
feron beta was reduced.16 The age-dependent defects in tation.22 Coronary heart disease has also been found to be
T-cell and B-cell function and the excess production of associated with acute cardiac events and poor outcomes
type 2 cytokines could lead to a deficiency in control of in influenza and other respiratory viral infections.22–24 In
viral replication and more prolonged proinflammatory this study, increased high-sensitivity cardiac troponin I
responses, potentially leading to poor outcome.17 during hospitalisation was found in more than half of
SOFA score is a good diagnostic marker for sepsis those who died. The first autopsy of a 53-year-old woman
and septic shock, and reflects the state and degree of with chronic renal failure in Jinyintan Hospital showed
multi-organ dysfunction.18,19 Although bacterial infec- acute myocardial infarction (data not published; personal
tions are usually regarded as a leading cause of sepsis, communication with a pathologist from the Chinese
viral infection can also cause sepsis syndrome. Previ- Academy of Science). About 90% of inpatients with
ously, we determined that sepsis occurred in nearly pneumonia had increased coagulation activity, marked by
40% of adults with community-acquired pneumonia due increased d-dimer concentrations.25 In this study, we
to viral infection.20 In the current study, we found that found d-dimer greater than 1 µg/mL is associated with
more than half of patients developed sepsis. Additionally, fatal outcome of COVID-19. High levels of d-dimer have a
we found that more than 70% of patients had white reported association with 28-day mortality in patients
blood cell count below 10·0 × 10⁹ per L or procalcitonin with infection or sepsis identified in the emergency
below 0·25 ng/mL, and no bacterial pathogens were department.26 Contributory mechanisms include systemic
detected in these patients on admission. Sepsis was a pro-inflammatory cytokine responses that are mediators
common complication, which might be directly caused of atherosclerosis directly contributing to plaque rupture
by SARS-CoV-2 infection, but further research is needed through local inflammation, induction of procoagulant
Why Do We Need Antibody Test for Covid-19 and How to Interpret
to investigate the pathogenesis of sepsis in COVID-19 factors, and haemodynamic changes, which predispose to
Test Results, Diazyme Laboratories, 2020
illness.
Figure 1: Variation of the Levels of ischaemia and thrombosis.27–29
SARS-CoV-2 RNAIn addition,
and angiotensin
Antigen, IgM and IgG after infection.
How Should We Interpret IgM/IgG Serological Test Results?
The present IgM/IgG serological assay is designed to complement RT-qPCR in the diagnosis of SARS-
CoV-2 infections. Table 1 shows the clinical interpretation of all possible scenarios that can be
Why Do We Need Antibody Test for Covid-19 and How to Interpret
encountered when testing a patient with both RT-qPCR and an IgM/IgG serological test.
Test Results, Diazyme Laboratories, 2020 Figure 1: Variation of the Levels of SARS-CoV-2 RNA and Antigen, IgM and IgG after infection.
References:
1. Weaver, C. Questions About Accuracy of Coronavirus Tests Sow Worry. The Wall Street Journal.
April 2nd, 2020. Retrieved from https://www.wsj.com/articles/questions-about-accuracy-of-coronavirus-
tests-sow-worry-11585836001
(OTG)
2. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman J2. Substantial undocumented infection
facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020 Mar 16. pii:
eabb3221.
3. Lauer, S. et al., 2020. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From
Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine.
4. National Health Commission of the People’s Republic of China, New Coronavirus Pneumonia
Diagnosis and Treatment Program (Trial Version 7).
5. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC et al. (2020). Temporal profiles of viral load
in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-
CoV-2: an observational cohort study. Lancet Infect Dis. 2020 Mar 23. pii: S1473-3099(20)30196-1.
MK 244 Rev. A
McDaniel S, Campbell T, Hepworth J, Lorenz A. Family-Oriented Primary Care. 3rd ed. Springer Publishing Company; 2013
PENGELOLAAN KO-MORBID/POPULASI KHUSUS
Diabetes Penyakit
Geriatri Autoimun STEMI
Mellitus Ginjal
Komunikasi
Masyarakat (PHBS Pemantauan dan Pemeriksaan RDT
analisis kasus ILI, Surveilans OTG, dan pengambilan
dan Physical ODP, PDP
ISPA, Pneumonia spesimen PCR
Distancing)
Pelaporan
berjenjang
PRIMARY, SECONDARY, TERTIARY PREVENTION